omega-n-methylarginine has been researched along with 8-bromoguanosino-3',5'-cyclic monophosphorothioate in 1 studies
Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (8-bromoguanosino-3',5'-cyclic monophosphorothioate) | Trials (8-bromoguanosino-3',5'-cyclic monophosphorothioate) | Recent Studies (post-2010) (8-bromoguanosino-3',5'-cyclic monophosphorothioate) |
---|---|---|---|---|---|
4,411 | 344 | 336 | 90 | 0 | 27 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Laurentiis, A; Duvilanski, B; Lasaga, M; Pisera, D; Rettori, V; Seilicovich, A | 1 |
1 other study(ies) available for omega-n-methylarginine and 8-bromoguanosino-3',5'-cyclic monophosphorothioate
Article | Year |
---|---|
Neurokinin A inhibits oxytocin and GABA release from the posterior pituitary by stimulating nitric oxide synthase.
Topics: Animals; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; gamma-Aminobutyric Acid; Hypothalamus; In Vitro Techniques; Male; Neurokinin A; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Oxytocin; Pituitary Gland, Posterior; Potassium; Rats; Rats, Wistar; Thionucleotides | 2000 |